ESC 365 - Adequacy of endogenous erythropoietin levels in anaemic heart failure patients - relationship with disease severity and co-morbidities

Back

ESC Premium Access

Adequacy of endogenous erythropoietin levels in anaemic heart failure patients - relationship with disease severity and co-morbidities

Session: New targets for biomarkers in heart failure

Topic: Pathophysiology and diagnosis

Speaker: Doctor M. Tkaczyszyn (Wroclaw, PL)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Michal Tkaczyszyn

Wroclaw Medical University, Wroclaw (Poland)

0 follower

6 more presentations in this session

NEOD001 demonstrates cardiac biomarker responses in patients with light chain amyloidosis and persistent organ dysfunction: results from the expansion phase of a phase 1/2 study

Speaker: Assistant Professor M. Liedtke (Stanford, US)

Access

Abstract

Changes in BNP prior to major cardiovascular events in patients with type 2 diabetes and a recent coronary event

Speaker: Doctor E. Wolsk (Herlev, DK)

Access

Abstract

Slides

Novel biomarkers in heart failure with reduced and preserved ejection fraction in the general population

Speaker: Doctor C. Sinning (Hamburg, DE)

Access

Abstract

Slides

Increased levels of urinary biomarkers of tubular injury as a predictor of poor diuretic response in acute heart failure

Speaker: Doctor M. Sokolski (Wroclaw, PL)

Access

Abstract

Slides

Association between brain natriuretic peptide levels and left ventricular ejection fraction in patients with preserved left ventricular ejection fraction.

Speaker: Assistant Professor S. Kitada (Nagoya, JP)

Access

Abstract

Slides

Access the full session

New targets for biomarkers in heart failure

Speakers: Doctor M. Tkaczyszyn, Assistant Professor M. Liedtke, Doctor E. Wolsk, Doctor C. Sinning, Doctor M. Sokolski...

Access

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources